Mylan S.A.S
9 products tracked · names used in filings: Mylan S.A.S, Mylan S.A.S.
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Docetaxel Mylan docetaxel | Application withdrawn | |
| 🇪🇺 | Ogivri | Application withdrawn | |
| 🇪🇺 | Alendronic Acid / Colecalciferol Mylan alendronate sodium trihydrate;colecalciferol | Application withdrawn | |
| 🇪🇺 | Aripiprazole Mylan aripiprazole | Application withdrawn | |
| 🇪🇺 | Rotigotine Mylan rotigotine | Application withdrawn | |
| 🇪🇺 | Fulphila pegfilgrastim | Application withdrawn | |
| 🇪🇺 | Pregabalin Mylan Pharma pregabalin | Withdrawn | 2015-06-25 |
| 🇪🇺 | Docetaxel Mylan docetaxel | Lapsed | 2012-01-31 |
| 🇪🇺 | Ribavirin Mylan (previously Ribavirin Three Rivers) ribavirin | Withdrawn | 2010-06-10 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.